Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma
Sun Min Lim, Jeong Eun Yoo, Kiat Hon Lim, David Wai Meng Tai, Byoung Chul Cho, Young Nyun Park
Cancer Res Treat. 2017;49(1):185-192. Published online 2016 Apr 27 DOI: https://doi.org/10.4143/crt.2015.497
|
Citations to this article as recorded by
Current treatment and novel insights regarding ROS1‐targeted therapy in malignant tumors
Shizhe Li, He Zhang, Ting Chen, Xiaowen Zhang, Guanning Shang
Cancer Medicine.2024;[Epub] CrossRef Molecular Analysis of Biliary Tract Cancers with the Custom 3′ RACE-Based NGS Panel
Natalia V. Mitiushkina, Vladislav I. Tiurin, Aleksandra A. Anuskina, Natalia A. Bordovskaya, Anna D. Shestakova, Aleksandr S. Martianov, Mikhail G. Bubnov, Anna S. Shishkina, Maria V. Semina, Aleksandr A. Romanko, Ekaterina S. Kuligina, Evgeny N. Imyanito
Diagnostics.2023; 13(20): 3168. CrossRef ROS1-dependent cancers — biology, diagnostics and therapeutics
Alexander Drilon, Chelsea Jenkins, Sudarshan Iyer, Adam Schoenfeld, Clare Keddy, Monika A. Davare
Nature Reviews Clinical Oncology.2021; 18(1): 35. CrossRef A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine‐based chemotherapy in patients with advanced solid tumors
Christos Fountzilas, Alex Adjei, Mateusz Opyrchal, Rachel Evans, Mohammad Ghasemi, Kristopher Attwood, Adrienne Groman, Wiam Bshara, Andrew Goey, John Wilton, Wen Wee Ma, Renuka Iyer
International Journal of Cancer.2021; 149(12): 2063. CrossRef Liver Mass in a Young Male With Ollier Disease
Rajalakshmi Govalan, Maha Guindi, Ju Dong Yang
Gastroenterology.2021; 161(5): e4. CrossRef Characteristics of Patients With ROS1+ Cancers: Results From the First Patient-Designed, Global, Pan-Cancer ROS1 Data Repository
Divya A. Parikh, Guneet Walia, Janet Freeman-Daily, Merel Hennink, Tori Tomalia, Lysa Buonanno, Lisa Goldman, Bonnie Addario, Manali I. Patel
JCO Oncology Practice.2020; 16(2): e183. CrossRef Testing for ROS1, ALK, MET, and HER2 rearrangements and amplifications in a large series of biliary tract adenocarcinomas
Jeremy Augustin, Caroline Gabignon, Aurélie Scriva, Laëtitia Menu, Claire Calmel, Olivier Scatton, François Paye, Jean-François Fléjou, Françoise Praz, Pascale Cervera, Dominique Wendum
Virchows Archiv.2020; 477(1): 33. CrossRef Response to Crizotinib in ROS1 Fusion–Positive Intrahepatic Cholangiocarcinoma
Christopher D. Jakubowski, Aditya A. Mohan, Ihab R. Kamel, Mark Yarchoan
JCO Precision Oncology.2020; (4): 825. CrossRef Emerging pathways for precision medicine in management of cholangiocarcinoma
Amir A. Rahnemai-Azar, Arezou Abbasi, Alexandra W. Acher, Sharon M. Weber, Timothy M. Pawlik
Surgical Oncology.2020; 35: 47. CrossRef Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients
Se-Hoon Lee, Boram Lee, Joon Ho Shim, Kwang Woo Lee, Jae Won Yun, Sook-Young Kim, Tae-You Kim, Yeul Hong Kim, Young Hyeh Ko, Hyun Cheol Chung, Chang Sik Yu, Jeeyun Lee, Sun Young Rha, Tae Won Kim, Kyung Hae Jung, Seock-Ah Im, Hyeong-Gon Moon, Sukki Cho, J
Cancer Research and Treatment.2019; 51(1): 211. CrossRef Molecular genetic aspects of intrahepatic cholangiocarcinoma: literature review
B. N. Gurmikov, Yu. A. Kovalenko, V. A. Vishnevsky, A. V. Chzhao
Advances in molecular oncology.2019; 6(1): 37. CrossRef Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives
Roberto Filippi, Pasquale Lombardi, Virginia Quarà, Elisabetta Fenocchio, Giacomo Aimar, Michela Milanesio, Francesco Leone, Massimo Aglietta
Expert Opinion on Pharmacotherapy.2019; 20(17): 2121. CrossRef Intrahepatic cholangiocarcinoma: current management and emerging therapies
Amir A. Rahnemai-Azar, Allison B. Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik
Expert Review of Gastroenterology & Hepatology.2017; 11(5): 439. CrossRef ROS1-1
Prodipto Pal, Zanobia Khan
Journal of Clinical Pathology.2017; 70(12): 1001. CrossRef
|